GERN Archives - Page 7 of 7

3 minute read

Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket

September 27, 6:29 AM

Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.

AKBA

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

September 13, 1:36 PM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ALT

3 minute read

Recap Of Monday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

August 22, 7:10 PM

The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery…

BLTE

1 minute read

Geron Commences Initial-Stage Rare Blood Cancer Combination Study

By Ragothaman Srinivasan

August 22, 6:22 PM

Geron Corporation (NASDAQ: GERN) has dosed first patient in IMproveMF study evaluating imetelstat in combination with ruxolitinib for patients with frontline myelofibrosis (MF).

GERN

1 minute read

Cowen Slashes Price Target On This Stock By Over 78%; Also Check Out Some Other Big PT Changes

By Lisa Levin

August 12, 9:14 AM

Cowen & Co. cut the price target for The RealReal, Inc. (NASDAQ: REAL) from $14 to $3. RealReal shares fell 0.7% to $3.1388 in pre-market trading.

1 minute read

Geron Q2 EPS $(0.07) Beats $(0.09) Estimate, Sales $73.00K Miss $110.00K Estimate

By Benzinga Newsdesk

August 11, 5:17 PM

Geron (NASDAQ:GERN) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.09) by 22.22 percent. This is a 22.22 percent increase over losses of $(0.09) per share from the same

GERN

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

August 11, 5:09 AM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG

Feed Symbols: GERN

Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket

10 Health Care Stocks Whale Activity In Today’s Session

Recap Of Monday’s Biotech Catalysts – End Of the Day Summary

Geron Commences Initial-Stage Rare Blood Cancer Combination Study

Cowen Slashes Price Target On This Stock By Over 78%; Also Check Out Some Other Big PT Changes

Geron Q2 EPS $(0.07) Beats $(0.09) Estimate, Sales $73.00K Miss $110.00K Estimate

Earnings Scheduled For August 11, 2022